Advertisement

Ideal medication review in older patients with cancer should include evaluation of frailty and prescription omission: Comment on the perspective “How-to-guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Group initiative”

Published:September 13, 2022DOI:https://doi.org/10.1016/j.jgo.2022.09.004
      We have read the perspective entitled “How-to-guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Group initiative” with great enthusiasm [
      • Kantilal K.
      • Kantilal K.
      • Nightingale G.
      • Ramsdale E.
      How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative.
      ]. Authors pointed out that older adults with cancer are at increased risk of and should be assessed for polypharmacy and/or potentially inappropriate medication use (PIM). They recommended that when polypharmacy and/or PIM is encountered, preferably a multidisciplinary team should perform a medication review (MR) in order to avoid treatment related harms and ensure that the benefit of treatments outweigh the risks. Subsequently, they summarized the interventions that should be included in the MR in five steps (i.e., i. Obtain a full medication history, ii. Monitor adherence, iii. Identify PIMs, iv. Identify interactions, v. Deprescribing) [
      • Kantilal K.
      • Kantilal K.
      • Nightingale G.
      • Ramsdale E.
      How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kantilal K.
        • Kantilal K.
        • Nightingale G.
        • Ramsdale E.
        How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative.
        J Geriatr Oncol. 2022; S1879-4068 (00133-3)
        • Ibrahim K.
        • Cox N.J.
        • Stevenson J.M.
        • Lim S.
        • Fraser S.D.S.
        • Roberts H.C.
        A systematic review of the evidence for deprescribing interventions among older people living with frailty.
        BMC Geriatr. 2021; 21: 258
        • Yilmaz O.
        • Aykent B.
        • Kucukdagli P.
        • Tascioglu C.
        • Bahat G.
        Frailty is associated with multimorbidities due to decreased physical reserve independent of age.
        Eur J Intern Med. 2019; 61 (e12-e3)
        • Bahat G.
        • Ozkok S.
        • Kilic C.
        • Karan M.A.
        SARC-F questionnaire detects frailty in older adults.
        J Nutr Health Aging. 2021; 25: 448-453
        • Bahat G.
        • Ilhan B.
        • Erdogan T.
        • Halil M.
        • Savas S.
        • Ulger Z.
        • et al.
        Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START.
        Eur Geriatr Med. 2020; 11: 491-498
        • O’Mahony D.
        • O’Sullivan D.
        • Byrne S.
        • O’Connor M.N.
        • Ryan C.
        • Gallagher P.
        STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.
        Age Ageing. 2015; 44: 213-218
        • Morley J.E.
        • Malmstrom T.K.
        • Miller D.K.
        A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans.
        J Nutr Health Aging. 2012; 16: 601-608
        • Bahat G.
        • Ilhan B.
        • Tufan A.
        • Dogan H.
        • Karan M.A.
        Success of simpler modified fried frailty scale to predict mortality among nursing home residents.
        J Nutr Health Aging. 2021; 25: 606-610
        • Catikkas N.M.
        • Bahat Z.
        • Oren M.M.
        • Bahat G.
        Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes.
        Aging Clin Exp Res. 2022; 34: 1747-1759
        • Bahat Z.
        • Bahat G.
        Evaluating sarcopenia in cancer patients: the role of muscle strength.
        Radiother Oncol. 2022; 172: 147-148
        • Volkert D.
        • Beck A.M.
        • Cederholm T.
        • Cruz-Jentoft A.
        • Goisser S.
        • Hooper L.
        • et al.
        ESPEN guideline on clinical nutrition and hydration in geriatrics.
        Clin Nutr. 2019; 38: 10-47
        • Bahat G.
        • Tufan F.
        • Tufan A.
        • Karan M.A.
        The ESPEN guidelines on enteral nutrition-geriatrics: need for its promotion in practice.
        Clin Nutr. 2016; 35: 985
        • Catikkas N.M.
        • Karan M.A.
        • Bahat Z.
        • Bahat G.
        Clinicians’ weak practice: nutritional therapy is required for the risk of malnutrition as well as malnutrition in older adults.
        Clin Nutr. 2022; 41: 2067-2068
        • Bahat G.
        • Ilhan B.
        • Erdogan T.
        • Halil M.
        • Savas S.
        • Ulger Z.
        • et al.
        Presenting Turkish inappropriate medication use in the elderly (TIME) criteria set in Turkish.
        Eur J Geriatr Gerontol. 2021; 3: 40-100